New Group Leader Recruitment Now Open (MI/25/54) | Cancer Research UK Manchester Institute We are seeking to appoint exceptional early-career scientists, including clinician scientists, as Group Leaders to develop bold, innovative, and high-impact research programmes.

We welcome applicants with expertise in the #biology of #SolidCancers, #TumourImmunology, #CancerEvolution, & computational/ #ML approaches to #tumour ecosystems; but we encourage visionary proposals from across the spectrum of #CancerResearch that complement & expand our existing strengths

#CanSky

eXmoor and Signadori Bio enter cell therapy partnership - PharmaTimes Signadori is advancing a platform designed to overcome the challenges of treating solid cancers

#Celltherapy #eXmoorpharma #SignadoriBio #solidtumours #Signadori #solidcancers #genemodifiedmonocytederivedmacrophagecelltherapyprogramme #cellandgenetherapy #genemodifiedmonocytes #translationalscience #nextgenerationmonocytebasedtherapies
pharmatimes.com/news/exmoor-...

IL-15 improves the effectiveness of GPC3 CAR T cells in targeting solid tumors The study reveals IL-15's role in enhancing GPC3 CAR T cell therapy, improving tumor targeting and T cell survival in patients with solid cancers.

IL-15 improves the effectiveness of GPC3 CAR T cells in targeting solid tumors

Read more: www.news-medical.net/news/2024120...

#cancer #solidcancers #tumour